Morgan Stanley downgrades Halozyme stock rating on valuation
Covered in this story
Analyst targets on Morgan Stanley
- Morgan Stanley: at $216 · target $215 by Jul 2027 via GuruFocus
- RBC Capital Markets: at $211 · target $243 by Jul 2027 · Sector Perform via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Morgan Stanley →Dalsna Finance is currently tracking 54 stories mentioning Morgan Stanley, the earliest published 28 Jul 2016.
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.